Skip to main content
. Author manuscript; available in PMC: 2013 Apr 23.
Published in final edited form as: Am J Physiol Heart Circ Physiol. 2004 Nov 4;288(3):H1314–H1323. doi: 10.1152/ajpheart.00618.2004

Table 2.

Myocardial expression of PPAR-γ isoforms

Ischemic-Reperfused Region
 NonIschemic Region
Group PPAR-γ1 PPAR-γ2 PPAR-γ1 PPAR-γ2
Untreated 1.00±0.11 1.00±0.10 1.00±0.15 1.00±0.12
Troglitazone 1.25±0.16 1.73±0.09* 1.23±0.14 1.75±0.06*
Rosiglitazone 1.69±0.12* 2.17±0.15* 1.65±0.23 2.29±0.43*
α-Tocopherol 0.98±0.05 1.00±0.07 1.47±0.15 1.28±0.08

Values are means ± SE; n = 5. Data were determined from ribonuclease protection assays. For each sample, bands corresponding to PPAR-γ1 and PPAR-γ2 were normalized to the band corresponding to GAPDH. Mean values of these ratios in the untreated group were assigned a value of 1.00, and values for the other groups are expressed as a fraction of the untreated group.

*

P < 0.05 vs. untreated.